GlassScriptPhysician profile
Hilla Steinberg
NPI 1053451286
$2,496.53
in general payments reported to CMS, 2019-2025
18 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $185 · 2021: $306 · 2022: $335 · 2023: $498 · 2024: $499 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,436 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.03 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $449.95 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Bausch & Lomb Americas INC. | $384.68 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $334.47 | 2022-2025 | Simbrinza, Rocklatan, Eysuvis |
| Allergan, INC. | $272.38 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $244.94 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $172.60 | 2019-2023 | Cequa |
| Aerie Pharmaceuticals, INC. | $121.35 | 2021 | |
| Merz North America, INC. | $78.20 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $76.98 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $76.57 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $63.98 | 2020 | |
| Kala Pharmaceuticals, INC. | $60.91 | 2021-2022 | |
| Thea Pharma INC. | $47.31 | 2024-2025 | Iyuzeh |
| Horizon Therapeutics Plc | $32.40 | 2023 | Tepezza |
| Amgen INC. | $25.49 | 2024 | Tepezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $21.13 | 2024 | Vevye |
| Shire North American Group INC | $19.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilla Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.